Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

1
Player Avatar dividendsrus (84.36) Submitted: 2/10/2012 10:46:55 AM : Outperform Start Price: $31.51 BMY Score: +5.24

Solid dividend payer should outperform over time.

Report this Post Reply

Featured Broker Partners


Advertisement